EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Positive AMPA and Kainate Receptor Modulators and Their Therapeutic Potential in CNS Diseases: A Comprehensive Review

Alina Vialko iD, Paulina Chałupnik, Ewa Szymańska iD

International Journal of Molecular Sciences · 04.07.2025 · 26 (13) · 6450

DOI: 10.3390/ijms26136450 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.07.2025. Verfasst von Alina Vialko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College in Kraków, PL 30-688 Kraków, Poland. Hauptthemen laut MEDLINE: Kainic Acid Receptors, Receptors, AMPA, Central Nervous System Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 199 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ionotropic glutamate receptors—including N-methyl-d-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and kainate receptors—play a pivotal role in excitatory signaling in the central nervous system (CNS), which is particularly important for learning and memory processes. Among them, AMPA and kainate receptors (known as ‘non-NMDA’ receptors) have gained increasing attention as therapeutic targets for various CNS disorders. Positive allosteric modulators (PAMs) of these receptors enhance their activity without directly activating them, offering a promising strategy to fine-tune glutamatergic signaling with potentially fewer side effects compared to orthosteric agonists. This review presents a comprehensive overview of recent advances in the development of AMPA and kainate receptor PAMs. We classify the most relevant modulators into main chemotype groups and discuss their binding modes, structure–activity relationships, and efficacy as determined through in vitro and in vivo studies. Additionally, we provide an overview of AMPA receptor PAMs that have entered into clinical trials over the past few decades. The increasing interest in kainate receptor PAMs is also mentioned, underlining their emerging role in future neuropharmacological strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kainic Acid ReceptorsReceptors, AMPACentral Nervous System DiseasesHumansAnimalsAllosteric RegulationStructure-Activity Relationship

Stichwörter der Autor:innen

AMPA receptorsclinical trialscognitive enhancerskainate receptorspositive allosteric modulatorspreclinical studies

Substanzen

Kainic Acid ReceptorsReceptors, AMPA

Autor:innen und Institutionen

  • Department of Technology and Biotechnology of Drugs, Jagiellonian University Medical College in Kraków, PL 30-688 Kraków, Poland.
  • Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, PL 31-530 Krakow, Poland.

ORCID-Profile: Alina Vialko, Ewa Szymańska

Zitieren

APA

Vialko, A., Chałupnik, P., & Szymańska, E. (2025). Positive AMPA and Kainate Receptor Modulators and Their Therapeutic Potential in CNS Diseases: A Comprehensive Review. International Journal of Molecular Sciences, 26(13), 6450. https://doi.org/10.3390/ijms26136450

Vancouver

Vialko A, Chałupnik P, Szymańska E. Positive AMPA and Kainate Receptor Modulators and Their Therapeutic Potential in CNS Diseases: A Comprehensive Review. International Journal of Molecular Sciences. 2025;26(13):6450. doi:10.3390/ijms26136450

BibTeX
@article{Vialko2025,
  author = {Vialko, Alina and Chałupnik, Paulina and Szymańska, Ewa},
  title = {Positive AMPA and Kainate Receptor Modulators and Their Therapeutic Potential in CNS Diseases: A Comprehensive Review},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {13},
  pages = {6450},
  doi = {10.3390/ijms26136450}
}
Kostenlos starten →